Dr. Li is planning for a career in non-malignant hematology, with a long-term career goal of becoming an academic hematologist and clinical researcher in the field of coagulation medicine.
PrintFriendly
-
NHF Announces New NHF-Shire Clinical Fellowship Award Recipient
-
uniQure Announces First Hemophilia B Patient Treated in Phase III Gene Therapy Trial
The trials is for uniQure investigational gene therapy treatment for patients with severe and moderately severe hemophilia B.
-
Providers: NHLBI Seeking Comment on Preliminary Hemophilia Inhibitors Measurement Protocols
NHLB is currently seeking feedback on hemophilia inhibitors measures proposed for inclusion in the PhenX Toolkit (consensus measures for Phenotypes and eXposures).
-
Roche Announces Donation of Hemlibra® to WFH Humanitarian Aid Program
The donation includes product as well as integrated care development training.
-
Travel Grants to NHF's Bleeding Disorders Conference Available / Becas de viaje disponibles para la Conferencia de Trastornos Hemorrágicos de NHF
Connections for Learning and Anna DeSimone travel grant applications are now open.
Becas de viaje disponibles para la Conferencia de Trastornos Hemorrágicos de NHF.
-
Court Issues Final Judgement in Shire/Roche Patent Lawsuit
The case was ruled in favor of Genentech.
-
ISTH Creates Bleeding Assessment Tool for Hemophilia Patients
The International Society on Thrombosis and Hemostasis (ISTH) recently developed a new tool to help clinicians identify and measure the severity of bleeding symptoms.
-
Gene Therapy with Transplanted Cells Shows Promise in Hemophilia A Mice
Researchers from the University of California (UC) Davis have been investigating whether two genetically engineered cell types could be customized for long term therapeutic benefit in individuals with hemophilia A.